Full Text View
Tabular View
No Study Results Posted
Related Studies
Iressa Expanded Access Program (EAP)
This study has been completed.
Study NCT00034879   Information provided by AstraZeneca
First Received: May 2, 2002   Last Updated: January 15, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Carcinoma
Non-Small-Cell Lung
Metastases
Neoplasm
Additional conditions recognized in this trial
Carcinoma, Non-Small-Cell Lung
Neoplasm Metastasis
Neoplasms
More general conditions related to this trial
Lung Diseases
Lung Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Neoplastic Processes
Pathologic Processes
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Thoracic Neoplasms
Interventions listed in this trial
ZD1839 (Gefitinib)
Additional drug interventions recognized in this trial
Gefitinib
More general drug interventions related to this trial
Antineoplastic Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protein Kinase Inhibitors
Therapeutic Uses
Sponsors listed in this trial
AstraZeneca


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services